lower percentage of macrophages: lymphocytes
- 41.320.1vs.17.17%,p¼0.001 and
macrophages – 52.319.2vs. 81.215 %,
p¼0.003. The counts of neutrophils and
eosinophils were inappreciably different between
the patients and controls. The percentage of CD
- was higher in BALF of BBS patients than that
in controls – 45.115.2 vs. 8.30.2 %,
p¼0.001. There was an inappreciable differ-
ence in CD8+ between the patients and healthy
subjects (16.83.2 vs. 18.14.2 %,
p¼0.121). The BALF recovery rate was similar
in the BBS and control groups.
BALF levels of OPG, sRANKL, and IL-
are shown in Fig. 1. The OPG concentration
was similar in the BBS patients and healthy
subjects [OPG: 0.22 (0.14–0.84) vs. 0.
(0.14–0.75) pmol/l, p¼0.744] (Fig.1a). The
sRANKL and IL-18 concentrations were signifi-
cantly greater in the BBS patients compared with
healthy subjects [sRANKL: 2.12 (0.82–10.23)
vs. 1.12 (0.79–4.39) pmol/l, p¼0.013; IL-18:
34.29 (12.5–133.70) vs. 13.05 (12.43–25.88)
pg/ml, p¼0.001] (Fig.1b, c ).
There were significant correlations between
sRANKL and IL-18 (r¼0.742, p¼0.0001)
(Fig. 2) and OPG and DLCO (r¼0.528,
p¼0.029) (Fig.3) in BALF of BBS patients.
Moreover, sRANKL correlated positively with
the percentage of lymphocytes (r¼0.60,
p¼0.003) and negatively with the percentage
of macrophages (r¼–0.58, p¼0.005) in these
patients. The correlations above outlined were
absent in the healthy group.
0.9 a
c
b
120
100
80
60
40
20
0
12
10
8
6
4
2
0
0.
0.
0.
0.
OPG in BALF (pmol/I)
IL-18 in BALF (pg/ml)
sRANKL in BALF (pmol/I)
0.
0.
0.
0.
Healthy
p = 0.744 p = 0.
p = 0.
Median
Min - Max
25-75%
BBS Healthy BBS
Healthy BBS
Fig. 1 (a) Concentration of osteoprotegerin (OPG); (b)
Soluble receptor activator of nuclear factor-kappaB
(sRANKL); and (c) interleukin-18 (IL-18) in
bronchoalveolar lavage fluid (BALF) of sarcoidosis
(BBS – Besniera-Boeck-Schaumann disease) patients
compared with those in healthy subjects
4 W. Naumnik et al.